support@activebiopharma.com
English
Menu
主页
产品目录
Inhibitors
AKT Inhibitors
ALK Inhibitor
ATM Inhibitor
Aurora Kinase Inhibitors
Bcl-2 Protein Family Inhibitors
B-Raf inhibitors
CDK inhibitors
c-Met Inhibitors
EGFR inhibitor
HDAC Inhibitors
Hedgehog inhibitor
HIV Inhibitor
JAK inhibitor
MEK inhibitor
mTOR Inhibitor
PARP inhibitor
PI3K Inhibitor
PKC Inhibitor
PLK1 Inhibitor
Other inhibitors
Activator
Agonist
antagonist
API
Aurora
Metabolic Disease
VEGFR-PDGFR
Other Intermediate
Others
MOF材料
关于我们
定制合成
订单和支付
联系我们
产品名字索引 K
主页
/
产品名字索引 K
Cas号索引
1
2
3
4
5
6
7
8
9
产品名字索引
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
CAS
化学名称
编号
分子式
1451255-59-6
KAN0438757
ABP013241
1038395-65-1
5-[4-[2-(4-吗啉基)乙氧基]苯基]-N-(苯基甲基)-2-吡啶乙酰胺盐酸盐
ABP009233
C26H29N3O3.ClH
897016-82-9
KX 01
ABP009232
C26H29N3O3
518058-84-9
KX1-004
ABP009231
1000669-72-6
[4-[2-(1H-吲唑-3-基)乙烯基]苯基]-1-哌嗪基甲酮
ABP009230
C20H20N4O
189224-48-4
2-(2-乙基-2,3-二氢-2-苯并呋喃基)-1H-咪唑
ABP009226
C13H14N2O
881375-00-4
KU-0060648
ABP009224
C33H34N4O4S.3ClH
286370-15-8
N-[2-氯-4-[(6,7-二甲氧基-4-喹唑啉基)氧基]苯基]-N'-丙基脲
ABP009223
C20H21ClN4O4
1472795-20-2
KRCA-0008
ABP009222
1421919-75-6
KPT-276
ABP009220
454453-49-7
KOBE-2602
ABP009218
436133-68-5
N-(3-CHLORO-4-METHYLPHENYL)-2-(2,6-DINITRO-4-(TRIFLUOROMETHYL)PHENYL)HYDRAZINECARBOTHIOAMIDE
ABP009217
1135280-28-2
KN-92 磷酸盐
ABP009213
1431698-47-3
KN-92 盐酸盐
ABP009212
525-79-1
激动素
ABP009209
C10H9N5O
672926-33-9
(ALPHAS)-1,4-二氢-ALPHA-异丙基-N-[4-甲基-5-(5-甲基-1,3,4-恶二唑-2-基)-2-噻唑基]-2,4-二氧代-3(2H)-喹唑啉乙酰胺
ABP009208
672926-32-8
2-[[(2S)-2-(1,4-二氢-2,4-二氧代-3(2H)-喹唑啉基)-3-甲基-1-氧代丁基]氨基]-4-甲基-5-噻唑羧酸乙酯
ABP009207
500863-50-3
KEVETRIN, NSC 525990
ABP009203
C5H9N3S.ClH
34580-14-8
酮替芬
ABP009202
C19H19NOS
22071-15-4
酮基布洛芬
ABP009199
C16H14O3
1208313-97-6
酮酯
ABP009198
C8H16O4
65277-42-1
酮康唑
ABP009197
C26H28Cl2N4O4
30233-64-8
二十二酸-1,2,3-丙三醇单酯
ABP009195
C25H50O4
« 上一页
1
2
3
4
5
6
下一页 »
Cas号索引
1
2
3
4
5
6
7
8
9
产品名字索引
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Copyright © 2015-2025 活性医药. All rights reserved. Support by
Moldb
.
浙ICP备11021315号-3
浙公网安备 33010802003999号
Scroll